217 related articles for article (PubMed ID: 28795244)
21. Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin.
Wieloch M; Jönsson KM; Själander A; Lip GY; Eriksson N; Svensson PJ
Thromb Res; 2013 Jun; 131(6):481-6. PubMed ID: 23351664
[TBL] [Abstract][Full Text] [Related]
22. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
[TBL] [Abstract][Full Text] [Related]
23. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
[TBL] [Abstract][Full Text] [Related]
24. Effect of oseltamivir on bleeding risk associated with warfarin therapy: a retrospective review.
Lee SH; Kang HR; Jung JW; Kwon JW; Hong KS; Yu KS; Cho SH
Clin Drug Investig; 2012 Feb; 32(2):131-7. PubMed ID: 22149150
[TBL] [Abstract][Full Text] [Related]
25. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.
Hylek EM; Held C; Alexander JH; Lopes RD; De Caterina R; Wojdyla DM; Huber K; Jansky P; Steg PG; Hanna M; Thomas L; Wallentin L; Granger CB
J Am Coll Cardiol; 2014 May; 63(20):2141-2147. PubMed ID: 24657685
[TBL] [Abstract][Full Text] [Related]
26. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score.
Lip GY; Frison L; Halperin JL; Lane DA
J Am Coll Cardiol; 2011 Jan; 57(2):173-80. PubMed ID: 21111555
[TBL] [Abstract][Full Text] [Related]
27. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective, multicenter, observational study.
Toyoda K; Yasaka M; Iwade K; Nagata K; Koretsune Y; Sakamoto T; Uchiyama S; Gotoh J; Nagao T; Yamamoto M; Takahashi JC; Minematsu K;
Stroke; 2008 Jun; 39(6):1740-5. PubMed ID: 18388341
[TBL] [Abstract][Full Text] [Related]
28. [Renal function in patients receiving long-term warfarin therapy: A five-year prospective follow-up].
Zemlyanskaya OA; Kropacheva ES; Dobrovolsky AB; Panchenko EP
Ter Arkh; 2017; 89(9):78-86. PubMed ID: 29039834
[TBL] [Abstract][Full Text] [Related]
29. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
[TBL] [Abstract][Full Text] [Related]
30. [INTERNATIONAL NORMALIZED RATIO VALUES AND HEMORRHAGE IN HOSPITALIZED PATIENTS STARTING WARFARIN THERPY: AN OBSERVATIONAL STUDY].
Abadi U; Ellis MH
Harefuah; 2015 Aug; 154(8):490-3, 541-2. PubMed ID: 26480611
[TBL] [Abstract][Full Text] [Related]
31. [Hemorrhagic complications of oral anticoagulant therapy: results of a prospective multicenter study ISCOAT (Italian Study on Complications of Oral Anticoagulant Therapy)].
Palareti G; Leali N; Coccheri S; Poggi M; Manotti C; D'Angelo A; Pengo V; Erba N; Moia M; Ciavarella N; Devoto G; Berretini M; Musolesi S
G Ital Cardiol; 1997 Mar; 27(3):231-43. PubMed ID: 9244725
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of postextraction bleeding incidence to compare patients receiving and not receiving warfarin therapy: a cross-sectional, multicentre, observational study.
Iwabuchi H; Imai Y; Asanami S; Shirakawa M; Yamane GY; Ogiuchi H; Kurashina K; Miyata M; Nakao H; Imai H
BMJ Open; 2014 Dec; 4(12):e005777. PubMed ID: 25510886
[TBL] [Abstract][Full Text] [Related]
33. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
[TBL] [Abstract][Full Text] [Related]
34. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
Perona S; Ford M; Rindone J
J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
[TBL] [Abstract][Full Text] [Related]
35. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
[TBL] [Abstract][Full Text] [Related]
36. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
37. Bleeding risk in patients with atrial fibrillation: the AMADEUS study.
Lane DA; Kamphuisen PW; Minini P; Büller HR; Lip GYH
Chest; 2011 Jul; 140(1):146-155. PubMed ID: 21415134
[TBL] [Abstract][Full Text] [Related]
38. No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedure.
Li HK; Chen FC; Rea RF; Asirvatham SJ; Powell BD; Friedman PA; Shen WK; Brady PA; Bradley DJ; Lee HC; Hodge DO; Slusser JP; Hayes DL; Cha YM
Pacing Clin Electrophysiol; 2011 Jul; 34(7):868-74. PubMed ID: 21410724
[TBL] [Abstract][Full Text] [Related]
39. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics.
Fihn SD; Callahan CM; Martin DC; McDonell MB; Henikoff JG; White RH
Ann Intern Med; 1996 Jun; 124(11):970-9. PubMed ID: 8624064
[TBL] [Abstract][Full Text] [Related]
40. Association of gene polymorphisms with the risk of warfarin bleeding complications at therapeutic INR in patients with mechanical cardiac valves.
An SH; Lee KE; Chang BC; Gwak HS
J Clin Pharm Ther; 2014 Jun; 39(3):314-8. PubMed ID: 24602049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]